Use of diuretics and risk of implant failure after primary total hip arthroplasty: A nationwide population-based study

Bone

Volumn 45, Issue 3, 2009, Pages 499-504

  Thillemann, Theis M ^a   Pedersen, Alma B ^a   Mehnert, Frank ^a   Johnsen, Søren P ^a   Søballe, Kjeld ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Diuretics; Loop; Prognosis; Thiazid; Total hip arthroplasty

Indexed keywords

BENDROFLUMETHIAZIDE; BUMETANIDE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOOP DIURETIC AGENT; POTASSIUM; THIAZIDE DIURETIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DATA BASE; DENMARK; DISLOCATION; DRUG USE; FEMALE; HIP DISEASE; HIP DISLOCATION; HIP FRACTURE; HIP OSTEOARTHRITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; POSTOPERATIVE PERIOD; PRESCRIPTION; PROSTHESIS FAILURE; PROSTHESIS INFECTION; PROSTHESIS LOOSENING; REGISTER; REOPERATION; RISK ASSESSMENT; SCHOOL CHILD; TOTAL HIP PROSTHESIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; CASE-CONTROL STUDIES; CHILD; DIURETICS; FEMALE; HIP PROSTHESIS; HUMANS; MALE; MIDDLE AGED; REOPERATION; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; THIAZIDES; YOUNG ADULT;

EID: 67949103532     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.04.247     Document Type: Article

References (27)

1. Rose B.D. Diuretics. Kidney Int. 39 2 (1991 February) 336-352
2. Bolland M.J., Ames R.W., Horne A.M., Orr-Walker B.J., Gamble G.D., and Reid I.R. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos. Int. 18 4 (2007 April) 479-486
3. Reid I.R., Ames R.W., Orr-Walker B.J., Clearwater J.M., Horne A.M., Evans M.C., et al. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am. J. Med. 109 5 (2000 October 1) 362-370
4. Rejnmark L., Vestergaard P., and Mosekilde L. Reduced fracture risk in users of thiazide diuretics. Calcif. Tissue Int. 76 3 (2005 March) 167-175
5. Schoofs M.W., van der K.M., Hofman A., de Laet C.E., Herings R.M., Stijnen T., et al. Thiazide diuretics and the risk for hip fracture. Ann. Intern. Med. 139 6 (2003 September 16) 476-482
6. Lim L.S., Fink H.A., Kuskowski M.A., Taylor B.C., Schousboe J.T., and Ensrud K.E. Loop diuretic use and increased rates of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Arch. Intern. Med. 168 7 (2008 April 14) 735-740
7. Rejnmark L., Vestergaard P., and Mosekilde L. Fracture risk in patients treated with loop diuretics. J. Intern. Med. 259 1 (2006 January) 117-124
8. Rejnmark L., Vestergaard P., Heickendorff L., Andreasen F., and Mosekilde L. Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. J. Bone Miner. Res. 21 1 (2006 January) 163-170
9. Johnsen S.P., Sorensen H.T., Lucht U., Soballe K., Overgaard S., and Pedersen A.B. Patient-related predictors of implant failure after primary total hip replacement in the initial, short- and long-terms: a nationwide Danish follow-up study including 36 984 patients. J. Bone Joint Surg. Br. 88 10 (2006 October) 1303-1308
10. Espehaug B., Havelin L.I., Engesaeter L.B., Langeland N., and Vollset S.E. Patient-related risk factors for early revision of total hip replacements. A population register-based case-control study of 674 revised hips. Acta Orthop. Scand. 68 3 (1997 June) 207-215
11. Furnes O., Lie S.A., Espehaug B., Vollset S.E., Engesaeter L.B., and Havelin L.I. Hip disease and the prognosis of total hip replacements. A review of 53,698 primary total hip replacements reported to the Norwegian Arthroplasty Register 1987-99. J. Bone Joint Surg. Br. 83 4 (2001 May) 579-586
12. Lucht U. The Danish Hip Arthroplasty Register. Acta Orthop. Scand. 71 5 (2000 October) 433-439
13. Pedersen A., Johnsen S., Overgaard S., Soballe K., Sorensen H.T., and Lucht U. Registration in the Danish Hip Arthroplasty Registry: completeness of total hip arthroplasties and positive predictive value of registered diagnosis and postoperative complications. Acta Orthop. Scand. 75 4 (2004 August) 434-441
14. Frank L. Epidemiology. When an entire country is a cohort. Science 287 5462 (2000 March 31) 2398-2399
15. Andersen T.F., Madsen M., Jorgensen J., Mellemkjoer L., and Olsen J.H. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan. Med. Bull. 46 3 (1999 June) 263-268
16. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40 5 (1987) 373-383
17. Lemann Jr. J., Gray R.W., Maierhofer W.J., and Cheung H.S. Hydrochlorothiazide inhibits bone resorption in men despite experimentally elevated serum 1,25-dihydroxyvitamin D concentrations. Kidney. Int. 28 6 (1985 December) 951-958
18. Barry E.L., Gesek F.A., Kaplan M.R., Hebert S.C., and Friedman P.A. Expression of the sodium-chloride cotransporter in osteoblast-like cells: effect of thiazide diuretics. Am. J. Physiol. 272 1 Pt 1 (1997 January) C109-C116
19. LaCroix A.Z., Ott S.M., Ichikawa L., Scholes D., and Barlow W.E. Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 133 7 (2000 October 3) 516-526
20. Herings R.M., Stricker B.H., de B.A., Bakker A., Sturmans F., and Stergachis A. Current use of thiazide diuretics and prevention of femur fractures. J. Clin. Epidemiol. 49 1 (1996 January) 115-119
21. Rejnmark L., Vestergaard P., Heickendorff L., Andreasen F., and Mosekilde L. Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover. J. Intern. Med. 257 2 (2005 February) 176-184
22. Heidrich F.E., Stergachis A., and Gross K.M. Diuretic drug use and the risk for hip fracture. Ann Intern. Med. 115 1 (1991 July 1) 1-6
23. Tromp A.M., Ooms M.E., Popp-Snijders C., Roos J.C., and Lips P. Predictors of fractures in elderly women. Osteoporos. Int. 11 2 (2000) 134-140
24. Carbone L.D., Johnson K.C., Bush A.J., Robbins J., Larson J.C., Thomas A., et al. Loop diuretic use and fracture in postmenopausal women: findings from the Women's Health Initiative. Arch. Intern. Med. 169 2 (2009 January 26) 132-140
25. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 362 9395 (2003 November 8) 1527-1535
26. Wu J., Kraja A.T., Oberman A., Lewis C.E., Ellison R.C., Arnett D.K., et al. A summary of the effects of antihypertensive medications on measured blood pressure. Am. J. Hypertens. 18 7 (2005 July) 935-942
27. Faris R., Flather M.D., Purcell H., Poole-Wilson P.A., and Coats A.J. Diuretics for heart failure. Cochrane Database Syst. Rev. 1 (2006) CD003838